Interarch Building Products secures orders worth Rs 221 crore in semiconductor and lithium-ion battery sector, from Tata Projects

Interarch Building Products on Sunday announced that it has received two major projects worth Rs 221 crore from Tata Projects. The first order, it added, is for Tata Semiconductor Assembly & Testing Pvt Limited, for their semiconductor manufacturing facility in Jagiroad, Morigaon, Assam. This is a key initiative in India’s growing semiconductor ecosystem, aligned with the government’s vision to boost domestic electronics manufacturing.

The second project, it informed, is for Agratas Energy Storage Solutions Pvt Ltd, for the construction of a lithium-ion battery manufacturing unit, in Sanand, Gujarat. The facility will cater to the rapidly growing energy storage market, supporting India’s transition to sustainable energy solutions. This is Interarch’ s second lithium-ion battery manufacturing order, after Exide Energy Solutions. 

Also ReadDMart Q3 Earnings: Avenue Supermarts posts profit growth of 4.79% at Rs 723.72 crore, announces leadership transition

In both these projects, TATA Projects Limited is the EPC contractor, the company said in a regulatory filing. 

Also Read South Western Railway announces partial cancellation, diversion of trains for track maintenance Poco F7, F7 Pro quick review: Limitless value?

Arvind Nanda, Managing Director, Interarch Building Products Ltd, said, “We are proud to partner with Tata Projects Limited on these transformative initiatives. The semiconductor and energy storage sectors are pivotal to India’s economic and technological future. Our flexible and industry-agnostic infrastructure solutions ensure efficiency, reliability, and sustainability in every project we undertake. These collaborations further reflect our commitment to driving innovation and growth across new-age industries.”

Interarch has engineered, designed, manufactured, and erected large projects for brands and emerging sectors such as data centres, renewable energy, and semiconductors. 

Earlier in September last year, Interarch had inaugurated phase 1 of the 5 state-of-art Pre-engineered steel (PEB) manufacturing plant (4th fully integrated unit) in Attivaram, Andhra Pradesh. The manufacturing facility is equipped with the updated technology and has capabilities to manufacture PEB structures and pre-engineered metal roofing and cladding systems, the company had said.

 » Read More

Related Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

‘Pramerica Life targets Rs 3,000-crore GWP in FY26,’ Pankaj Gupta

Pramerica Life Insurance, a joint venture between subsidiaries of Piramal Capital and Housing Finance and US-based Prudential Financial Inc, aims to close FY26 with Rs 3,000 crore in gross written premium. In an interview with Narayanan V, managing director and CEO Pankaj Gupta discusses the products and distribution strategy. Excerpts: Life insurance premiums have been

Tata small cap fund: Targeting growth at reasonable valuations

Tata Small Cap Fund is a growth-oriented scheme in the Small Cap Fund category that has exhibited a noteworthy track record since its inception and has outpaced many of its prominent peers, thereby rewarding investors with superior risk-adjusted returns. Launched in November 2018, Tata Small Cap Fund aims to invest in stocks of companies that are in growth